Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

At Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer, the Infectious Diseases portfolio includes studies focused on HIV-1 infection and related immune responses, with an emphasis on improving treatment strategies and understanding how therapy can shape long-term disease control.

• Evaluating new ways to support people living with HIV at the start of antiretroviral treatment
• Studying the safety of adding a targeted therapy to reduce the viral reservoir
• Advancing research in virus diseases and immune system diseases

This work aims to refine treatment approaches and improve outcomes for patients through safer and more effective clinical research.

The site is conducting research in respiratory tract diseases and immune system diseases, especially for asthma, with trials designed to help maintain symptom control while exploring more convenient treatment strategies.

• Testing whether adjusted treatment use can preserve stability in people with allergic asthma
• Assessing effects on flare-ups, lung function, and quality of life
• Supporting better long-term management of chronic airway disease

These studies focus on improving everyday disease control while keeping care practical and patient-centered.

Clinical trials in cardiovascular diseases at this Barcelona research site are centered on reducing complications after acute ischemic stroke and managing atrial fibrillation, with broader interest in lowering future cardiovascular risk.

• Studying early rhythm control to reduce serious outcomes after stroke
• Exploring better strategies for patients with irregular heartbeat and vascular risk
• Improving prevention of repeat events in high-risk heart and brain disease

The goal is to test treatment approaches that may help patients recover more safely and avoid additional cardiovascular events.

Research in digestive system diseases and related physiological processes includes studies in decompensated hepatic cirrhosis, where investigators are evaluating supportive care that may improve kidney recovery and overall clinical stability.

• Assessing treatment options for acute kidney injury in advanced liver disease
• Comparing approaches intended to improve organ function recovery
• Addressing complications linked to severe liver disease

This line of research reflects a strong focus on managing complex illness at the intersection of digestive and renal health.

The oncology program covers neoplasms and includes trials in HER2 positive or HER2-low metastatic breast cancer, basal cell carcinoma, and non-muscle-invasive bladder cancer, with a clear focus on testing new treatment options and improving disease control.

• Evaluating new therapies for advanced breast cancer
• Studying targeted approaches for bladder cancer with specific genetic alterations
• Investigating local treatment strategies for basal cell carcinoma

These studies aim to expand treatment choices for patients with difficult-to-treat cancers and support more personalized care.

The site also explores analytical, diagnostic and therapeutic techniques and equipment through studies in heterozygous familial hypercholesterolaemia and related lipid disorders, seeking better ways to assess and manage long-term cardiovascular risk.

• Testing treatments aimed at lowering LDL cholesterol in inherited lipid disease
• Improving prevention of future cardiovascular complications
• Supporting earlier and more effective risk reduction in high-cholesterol conditions

This research combines treatment evaluation with better disease monitoring to help patients with inherited metabolic risk.